Added to YB: 2026-08-11
Pitch date: 2026-07-08
GH [bullish]
Guardant Health, Inc.
+8.3%
current return
Author Info
Outlier Capital is where I share my highest-conviction ideas, portfolio updates, and investment research. Sign up for the newsletter.
Company Info
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
Market Cap
$22.6B
Pitch Price
$154.40
Price Target
1.5K (+796%)
Dividend
N/A
EV/EBITDA
-58.68
P/E
-48.09
EV/Sales
19.65
Sector
Health Care Providers and Services
Category
growth
Healthcare & Biotechnology AI Thesis (I) – 5 Stocks with Credible 10x+ Potential: Guardant Health (GH) – AI-Enhanced Liquid Biopsy & Genomics for Cancer (Precision Biotech Diagnostics)
GH: AI-driven liquid biopsy leader (ctDNA/multi-omic) for cancer detection & monitoring. FDA-approved expanded Guardant360 CDx (largest panel via InfinityAI); raised 2026 guide to 32-34% growth. ~$151/share, ~$20B cap. 10x thesis on volume, new indications, pharma dx deals. Risks: reimbursement, competition, regulatory.
Read full article (1 min)